Ascensia Diabetes Care
Ascensia Diabetes Care is a global company dedicated to improving the health and lives of people with diabetes. They create innovative products such as the CONTOUR® portfolio of blood glucose monitoring systems and are the exclusive global distribution partner for the Eversense® CGM Systems. Their mission is to serve the needs of patients through innovation and expertise in diabetes management, aiming to make a positive, daily difference in the lives of people with diabetes.
Industries
Nr. of Employees
Very Large (1000+)
Ascensia Diabetes Care
Münchenstein, Basel-Country, Switzerland
Patents
Devices, systems, and methods for measuring analytes in interstitial fluid
US-12303261-B2
View DetailsSterilized reusable wearable devices and wearable device forming methods in continuous analyte monitoring
US-12295745-B2
View DetailsContinuous analyte monitoring devices and systems having a long-life reusable wireless transmitter unit and application methods therefor
US-12290334-B2
View DetailsTracking insertion and removal times of a continuous glucose monitoring sensor
US-12257045-B2
View DetailsBase units, transmitter units, wearable devices, and methods of continuous analyte monitoring
US-12251218-B2
View Details
Devices, systems, and methods for measuring analytes in interstitial fluid
US-12303261-B2
View DetailsSterilized reusable wearable devices and wearable device forming methods in continuous analyte monitoring
US-12295745-B2
View DetailsContinuous analyte monitoring devices and systems having a long-life reusable wireless transmitter unit and application methods therefor
US-12290334-B2
View DetailsTracking insertion and removal times of a continuous glucose monitoring sensor
US-12257045-B2
View DetailsBase units, transmitter units, wearable devices, and methods of continuous analyte monitoring
US-12251218-B2
View DetailsProducts
CONTOUR NEXT blood glucose monitoring systems
Blood glucose monitoring systems intended for self-monitoring of blood glucose with features for accuracy and data connectivity.
Eversense continuous glucose monitoring system
A long-term wearable/implantable continuous glucose monitoring system for extended sensor wear and continuous glucose data.
Diabetes data management solutions
Mobile and cloud-based solutions for tracking blood glucose results, visualizing trends and enabling data sharing with healthcare professionals.
Contour Care
An automated system intended for the quantitative measurement of glucose in venous blood and fresh capillary whole blood drawn from the fingertip or palm, sold as part of the Contour Care Blood Glucose Monitoring System.
CONTOUR CARE Blood Glucose Test Strips
Blood glucose test strips designed to work with the CONTOUR CARE meter, featuring a small sample size requirement and Second-Chance sampling.
MICROLET
Intended for collecting capillary blood for blood glucose testing, for use together with disposable lancets from the fingertip or palm for a single patient.
CONTOUR NEXT blood glucose monitoring systems
Blood glucose monitoring systems intended for self-monitoring of blood glucose with features for accuracy and data connectivity.
Eversense continuous glucose monitoring system
A long-term wearable/implantable continuous glucose monitoring system for extended sensor wear and continuous glucose data.
Diabetes data management solutions
Mobile and cloud-based solutions for tracking blood glucose results, visualizing trends and enabling data sharing with healthcare professionals.
Contour Care
An automated system intended for the quantitative measurement of glucose in venous blood and fresh capillary whole blood drawn from the fingertip or palm, sold as part of the Contour Care Blood Glucose Monitoring System.
CONTOUR CARE Blood Glucose Test Strips
Blood glucose test strips designed to work with the CONTOUR CARE meter, featuring a small sample size requirement and Second-Chance sampling.
MICROLET
Intended for collecting capillary blood for blood glucose testing, for use together with disposable lancets from the fingertip or palm for a single patient.
Services
Business development, licensing and technology partnerships to enable device connectivity, app integrations and co-development of diabetes management solutions.
Commercial distribution, market launch and payer engagement support for diabetes monitoring systems across multiple regional markets.
Business development, licensing and technology partnerships to enable device connectivity, app integrations and co-development of diabetes management solutions.
Commercial distribution, market launch and payer engagement support for diabetes monitoring systems across multiple regional markets.
Expertise Areas
- Diabetes device commercialization
- Continuous glucose monitoring (CGM) market integration
- Blood glucose monitoring (BGM) device engineering
- Digital health integration and data interoperability
Key Technologies
- Blood glucose monitoring (BGM) systems
- Continuous glucose monitoring (CGM)
- Implantable glucose sensors
- Microneedle intradermal biosensors
News & Updates
The Eversense 365 has been recognized for its outstanding innovation as the world’s first and only one year CGM system, awarded by MedTech Breakthrough Awards.
Award recognizes the outstanding innovation of Eversense 365 as the world’s first and only one-year CGM system.
Ascensia and Senseonics integrate software between SweetSpot and Eversense 365, the world’s first and only One Year CGM system.
Ascensia created a virtual wellness zone to align with the IDF’s 2024 theme of ‘Diabetes and Well-being’.
MedTech Breakthrough Awards honor standout digital health and medical technology products and companies.
Recognizing the innovation of Eversense 365 as the world’s first and only one-year CGM.
The Eversense 365 has been recognized for its outstanding innovation as the world’s first and only one year CGM system, awarded by MedTech Breakthrough Awards.
Award recognizes the outstanding innovation of Eversense 365 as the world’s first and only one-year CGM system.
Ascensia and Senseonics integrate software between SweetSpot and Eversense 365, the world’s first and only One Year CGM system.
Ascensia created a virtual wellness zone to align with the IDF’s 2024 theme of ‘Diabetes and Well-being’.
MedTech Breakthrough Awards honor standout digital health and medical technology products and companies.
Recognizing the innovation of Eversense 365 as the world’s first and only one-year CGM.